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The neurohypophysial hormones of the l-month-old bovine fetus have been identified by their positions in ion-exchange 
chromatography and their retention times in high-pressure reverse-phase partition chromatography. Arginine vasopressin 
and oxytocin have been recognized. The molar ratio vasopressin/oxytocin in neurohypophysis is about 6 in the l-month- 
old fetus compared with 4 in the 3-month-old fetus, 2.7 in the 7-month-old fetus and 1 in the adult. Vasotocin is virtually 
absent even in the early fetus (less than 0.1% of arginine vasopressin). The occurrence of a vasotocin gene expressed in 
the fetus but silent in the adult appears unlikely. 
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1. INTRODUCTION 
Mammalian neurohypophysial hormones, vaso- 
pressin and oxytocin, are biosynthesized as protein 
precursors usually processed into a hormonal 
nonapeptide, a neurophysin and an additional 
glycopeptide, copeptin, in the case of vasopressin 
precursor. Cleavages occur during intracellular 
transport from the rough endoplasmic reticulum to 
secretory granules stored in neurone endings 
(reviews [ 1,2]). Processing is rarely incomplete at 
the level of neurohypophysis but a partial matura- 
tion was observed in guinea pig in which an in- 
termediate encompassing MSEL-neurophysin and 
copeptin and accounting for about 20% of the 
primordial precursor has been isolated and se- 
&enced [3]: 
Transient occurrence of 
pressin), usually regarded 
vasotocin ([Ile3]vaso- 
as a non-mammalian 
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neurohypophysial hormone [4], in sheep, seal and 
human fetuses, has been claimed on the basis of 
chromatographic, pharmacological and immuno- 
logical evidence [5-71. Biochemical research, 
however, carried out with 7-month- and 3-month- 
old bovine fetuses, on the one hand, failed to 
detect vasotocin and, on the other, allowed chem- 
ical characterization of oxytocin, vasopressin, 
MSEL- and VLDV-neurophysins and copeptin, all 
of which are identical to the corresponding adult 
polypeptides. These results showed that the same 
genes are expressed in fetus and adult and that pro- 
tein precursors are processed in the same way 
[8-lo]. Transient production of vasotocin in mam- 
mals would need preservation of an additional 
‘reptilian’ gene expressed only during the early 
stage of the development and silent in neonate and 
adult. Identification of vasotocin in the fetus 
would provide a support to the so-called ‘recapi- 
tulation law’ according to which ontogeny would 
recapitulate phylogeny. In this respect we have 
now examined bovine fetus at a very early stage, 
namely the l-month-old fetus, and compared the 
hormones with those of later fetuses and adults. 
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2. MATERIALS AND METHODS 
2.1. Pituitary glands 
Nine pituitaries from l-month-old bovine fetuses have been 
desiccated in pure and cold acetone and dissected into anterior 
and posterior lobes. The average weight of the dried posterior 
pituitary was 1.6 mg. 14.5 mg of powdered tissue have been 
used for two experiments (7 and 6.5 mg, respectively). Extrac- 
tion was carried out with hot 0.25% acetic acid (5 min, 100°C). 
The powder titrated at 0.10-0.13 U/mg uterotonic activity and 
0.62-0.79 U/mg pressor activity. 
2.2. Ion-exchange chromatography 
First ion-exchange chromatography was carried out on 
Amberlite IRC-50 under conditions separating oxytocin, 
vasotocin and arginine vasopressin [1 11. 7 mg of powder were 
extracted with 5 ml of 0.25% acetic acid and the centrifuged 
solution passed through a column (0.3 x 21 cm) equilibrated 
with 0.1 M ammonium acetate, pH 5.0. The hormones were ad- 
sorbed at the top and eluted with a pH and ionic strength gra- 
dient made first with 0.3 M acetate, pH 7.7, then with 0.6 M 
acetate, pH 7.7 (mixing flask, 10 ml). The flow rate was 
2 ml/h. 0.5-ml fractions were collected and bioassays carried 
out. 
2.3. High-pressure reverse-phase liquid chromatography 
(HPLC) 
6.5 mg of powder were extracted with 1.4 ml of 0.25% acetic 
acid and, after centrifugation and washing twice with 0.2 ml, 
the pooled solution (1.6 ml) was used for HPLC. A Nucleosil 
C-18 column (0.46 x 21 cm, particle size 5 pm), was employed 
with a Waters model 204 liquid chromatograph equipped with 
a model 680 automated gradient controller, a model 441 fixed 
wavelength absorbance detector (214 and 280 nm) and a model 
730 data module. After equilibration with a solvent containing 
15% acetonitrile/85% of 0.01 M sodium acetate, pH 5.0, a 
linear gradient was applied with a solvent containing 25% 
acetonitrile/75% of 0.01 M sodium acetate, pH 5.0, for 30 min 
at room temperature, followed by 5 min with the second sol- 
vent, the flow rate being 2 ml/min. 
3. RESULTS AND DISCUSSION 
3.1. Ion-exchange chromatographic identification 
The acetic acid extract of posterior pituitary 
powder containing 1.2 U oxytocic activity and 
5.6 U pressor activity has been chromatographed 
on Amberlite IRC-50 under conditions described 
and hormones detected by bioassays. Vasotocin is 
pharmacologically easy to distinguish from ox- 
ytocin and vasopressin because it displays both 
uterotonic (120 U/pmol) and pressor (240 U/ 
pmol) activities. A control experiment with authen- 
tic hormones, oxytocin (5 U), vasotocin (0.1 U) 
and arginine vasopressin (5 U), showed that oxyto- 
tin was recovered in tubes 90-110 with a yield of 
80%, vasotocin in tubes 160-200 with a yield of 
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70% and arginine vasopressin in tubes 222-270 
with a yield of 74010. In the case of l-month-old 
fetus, oxytocin was pharmacologically identified in 
tubes 90- 110 (yield in activity, 70%) and arginine 
vasopressin in tubes 222-270 (yield in activity, 
86%). At the vasotocin position (tubes 160-200), 
less than 2 mU oxytocic activity with magnesium 
and less than 6 mU pressor activity were detected. 
In other words, vasotocin, if present, would be 1% 
less than that of arginine vasopressin. 
3.2. High-pressure liquid chromatography 
identification 
The acetic acid solution injected contained 4.5 U 
pressor activity and 0.77 U oxytocic activity. Two 
peptides have been pharmacologically detected, 
one displaying pressor activity and having a reten- 
tion time of 20.70 min (20.8 min for authentic 
arginine vasopressin), the other possessing ox- 
ytocic activity and having a retention time of 
28.20 min (28.2 min for authentic oxytocin) 
(fig.1). The yields were 87% and 55%, respective- 
ly. At the retention time of synthetic vasotocin 
(13.15 min), and in fractions 14-29, less than 
2.8 mU oxytocic activity with magnesium was 
detected. It can be calculated that less than 
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Fig. 1. High-pressure reverse-phase partition chromatography 
of an acetic acid extract from a l-month-old bovine posterior 
pituitary. Neurohypophysial hormones have been located by 
their pharmacological activities (pressor activity for vasopres- 
sin, uterotonic activity for oxytocin) and identified by compari- 
son with synthetic peptides. Vasotocin would have been located 
at 13.15 min. 
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Fig.2. High-pressure reverse-phase partition chromatography 
of an acetic acid extract from a 3-month-old bovine pituitary. 
Neurohypophysial hormones have been identified by their 
retention times and their amino acid sequences. 
10 pmol vasotocin corresponding to less than 
0.07% arginine vasopressin could be present. 
When the same experiment is carried out with 
posterior pituitaries from 3-month-old bovine 
fetuses, the same neurohypophysial hormones, 
vasopressin and oxytocin, can be identified both 
by retention times in HPLC (fig.2) and microse- 
quencing [lo]. Again less than a molar proportion 
of 0.2% vasotocin compared to arginine 
vasopressin could be present at the vasotocin posi- 
tion on the chromatogram. 
3.3. Relative expression of oxytocin and 
vasopressin genes during the development 
The molar ratio of arginine vasopressin to ox- 
ytocin, deduced from the biological activities of 
the powders and the specific activities of the hor- 
mones is about 6 in the l-month-old fetus and 
about 4 in the 3-month-old fetus. Apparently, the 
oxytocin gene is expressed much less than 
vasopressin gene in the very early fetus, probably 
because the antidiuretic function of the kidney is 
already working whereas the reproduction ac- 
tivities in which oxytocin is involved (parturition 
and milk-ejecting action) are not. In several adult 
mammals uch as ox, sheep, pig and rat, the molar 
ratio of the two hormones is about 1 in the normal 
animal but it increases in the lactating female due 
to a large oxytocin secretion [12]. 
Neurophysins of the l-month-old fetuses have 
not been characterized because of the small 
amount of material but in the 3-month-old and the 
7-month-old fetuses, they have been shown to be 
identical to those of the adult ox [&lo]. We can 
therefore say that the same genes [13] are expressed 
during fetal and adult lives and that there is no 
evidence for an additional vasotocin gene ex- 
pressed only in the fetus. Vasotocin precursor has 
been identified in amphibians either directly in the 
frog Rana esculenta [ 141 or deduced from cDNA in 
the toad Bufo japonicus [15]. The organization in 
domains appears to be similar to that of the 
vasopressin precursor and the vasotocin gene 
probably resembles the vasopressin gene 
[13,16,17]. 
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